Allison Dorval Puma Biotechnology, Inc. (PBYI) insider trading activity

PBYI Quotes by TradingView

Allison Dorval is Director of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 60,000 shares of PBYI, which is worth approximately $177,000. The most recent transaction as insider was on Jun 18, 2024, when has been sold 27,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60K
0% 3M change
252.94% 12M change
Total Value Held $177,000

Allison Dorval Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Grant, award, or other acquisition
-
27,000 Added 31.03%
60,000 Common Stock
Jun 13 2024
SELL
Open market or private sale
$37,070 $3.37 p/Share
11,000 Reduced 25.0%
33,000 Common Stock
Jun 13 2023
SELL
Open market or private sale
$34,500 $3.45 p/Share
10,000 Reduced 37.04%
17,000 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
27,000 Added 38.03%
44,000 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
27,000 Added 50.0%
27,000 Common Stock

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
Chief Financial Officer
AVTE
Aerovate Therapeutics, Inc. Healthcare
VERV
Verve Therapeutics, Inc. Healthcare
Chief Financial Officer
AD

Allison Dorval

Director
Cambridge, MA

Track Institutional and Insider Activities on PBYI

Follow PUMA BIOTECHNOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBYI shares.

Notify only if

Insider Trading

Get notified when an Puma Biotechnology, Inc. insider buys or sells PBYI shares.

Notify only if

News

Receive news related to PUMA BIOTECHNOLOGY, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PBYI